Home LiteratureArticle Details
PMID: 24838857 Published · ppublish English Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.

European journal of immunology ·Vol. 44 ·No. 9 ·2014-09-00 ·Pages 2703-2711

Gautron AS, Dominguez-Villar M, de Marcken M, Hafler DA

Abstract

T-cell immunoglobulin and mucin domain 3 (TIM-3) is an Ig-superfamily member expressed on IFN-γ-secreting Th1 and Tc1 cells and was identified as a negative regulator of immune tolerance. TIM-3 is expressed by a subset of activated CD4(+) T cells, and anti-CD3/anti-CD28 stimulation increases both the level of expression and the number of TIM-3(+) T cells. In mice, TIM-3 is constitutively expressed on natural regulatory T (Treg) cells and has been identified as a regulatory molecule of alloimmunity through its ability to modulate CD4(+) T-cell differentiation. Here, we examined TIM-3 expression on human Treg cells to determine its role in T-cell suppression. In contrast to mice, TIM-3 is not expressed on Treg cells ex vivo but is upregulated after activation. While TIM-3(+) Treg cells with increased gene expression of LAG3, CTLA4, and FOXP3 are highly efficient suppressors of effector T (Teff) cells, TIM-3(-) Treg cells poorly suppressed Th17 cells as compared with their suppression of Th1 cells; this decreased suppression ability was associated with decreased STAT-3 expression and phosphorylation and reduced gene expression of IL10, EBI3, GZMB, PRF1, IL1Rα, and CCR6. Thus, our results suggest that TIM-3 expression on Treg cells identifies a population highly effective in inhibiting pathogenic Th1- and Th17-cell responses.

Keywords
FoxP3 Regulatory T (Treg) cells TIM-3 Th17
MeSH Terms
Animals Antigens, CD/immunology CTLA-4 Antigen/immunology Cell Differentiation/immunology Female Forkhead Transcription Factors/immunology Gene Expression Regulation/immunology Granzymes/immunology Hepatitis A Virus Cellular Receptor 2 Humans Interleukin 1 Receptor Antagonist Protein/immunology Interleukin-10/immunology Interleukins/immunology Male Membrane Proteins/immunology Mice Minor Histocompatibility Antigens Receptors, CCR6/immunology STAT3 Transcription Factor/immunology T-Lymphocytes, Regulatory/cytology,immunology Th17 Cells/cytology,immunology
Chemicals
Antigens, CD CCR6 protein, human CD223 antigen CTLA-4 Antigen CTLA4 protein, human EBI3 protein, human FOXP3 protein, human Forkhead Transcription Factors HAVCR2 protein, human Hepatitis A Virus Cellular Receptor 2 IL10 protein, human IL1RN protein, human Interleukin 1 Receptor Antagonist Protein Interleukins Membrane Proteins Minor Histocompatibility Antigens Receptors, CCR6 STAT3 Transcription Factor STAT3 protein, human Interleukin-10 GZMB protein, human Granzymes
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gautron Anne-Sophie
Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06520.
Dominguez-Villar Margarita
Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06520.
de Marcken Marine
Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06520.
Hafler David A
Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06520.
References (42)
42 references, click to expand
  1. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.
    Nat Immunol. 2003 Nov;4(11):1102-10 PMID: 14556006
  2. Role of LAG-3 in regulatory T cells.
    Immunity. 2004 Oct;21(4):503-13 PMID: 15485628
  3. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.
    Nature. 2008 Jul 17;454(7202):350-2 PMID: 18469800
  4. CD4⁺T cells: differentiation and functions.
    Clin Dev Immunol. 2012;2012:925135 PMID: 22474485
  5. Tim-3 expression defines regulatory T cells in human tumors.
    PLoS One. 2013;8(3):e58006 PMID: 23526963
  6. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.
    Nat Immunol. 2009 Jun;10(6):595-602 PMID: 19412181
  7. IL-17 and Th17 Cells.
    Annu Rev Immunol. 2009;27:485-517 PMID: 19132915
  8. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
    J Immunol. 2010 May 1;184(9):4696-707 PMID: 20351188
  9. TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.
    Oncoimmunology. 2013 Apr 1;2(4):e23849 PMID: 23734331
  10. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.
    Eur J Immunol. 2009 Sep;39(9):2492-501 PMID: 19676072
  11. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
    Nat Immunol. 2003 Nov;4(11):1093-101 PMID: 14556005
  12. Emerging Tim-3 functions in antimicrobial and tumor immunity.
    Trends Immunol. 2011 Aug;32(8):345-9 PMID: 21697013
  13. Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.
    Cancer Res. 2011 May 15;71(10):3540-51 PMID: 21430066
  14. Control of regulatory T cell development by the transcription factor Foxp3.
    Science. 2003 Feb 14;299(5609):1057-61 PMID: 12522256
  15. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
    Nature. 2009 Mar 19;458(7236):351-6 PMID: 19182775
  16. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.
    Science. 2009 Nov 13;326(5955):986-91 PMID: 19797626
  17. TIM-3 and its regulatory role in immune responses.
    Curr Top Microbiol Immunol. 2011;350:1-15 PMID: 20700701
  18. Immune checkpoints in central nervous system autoimmunity.
    Immunol Rev. 2012 Jul;248(1):122-39 PMID: 22725958
  19. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
    J Clin Invest. 2010 Dec;120(12):4546-57 PMID: 21084749
  20. Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
    J Clin Invest. 2012 Jul;122(7):2395-404 PMID: 22684103
  21. Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.
    Immunobiology. 2012 Oct;217(10):986-95 PMID: 22445722
  22. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
    J Immunol. 2012 Jul 15;189(2):755-66 PMID: 22706088
  23. CTLA-4 control over Foxp3+ regulatory T cell function.
    Science. 2008 Oct 10;322(5899):271-5 PMID: 18845758
  24. Role of Th1 and Th17 cells in organ-specific autoimmunity.
    J Autoimmun. 2008 Nov;31(3):252-6 PMID: 18502610
  25. Human CD4+CD25+ regulatory T cells.
    Semin Immunol. 2004 Apr;16(2):89-98 PMID: 15036232
  26. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.
    J Immunol. 2008 May 1;180(9):5916-26 PMID: 18424711
  27. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.
    Nat Rev Immunol. 2010 Dec;10(12):849-59 PMID: 21107346
  28. TIMs: central regulators of immune responses.
    J Exp Med. 2008 Nov 24;205(12):2699-701 PMID: 19015312
  29. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Eur J Immunol. 2010 Sep;40(9):2493-505 PMID: 20623550
  30. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
    Nature. 2002 Jan 31;415(6871):536-41 PMID: 11823861
  31. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.
    Am J Transplant. 2011 Apr;11(4):775-85 PMID: 21446979
  32. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
    PLoS One. 2012;7(2):e30676 PMID: 22363469
  33. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
    J Exp Med. 2010 Sep 27;207(10):2187-94 PMID: 20819927
  34. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C.
    J Gastroenterol Hepatol. 2012 Feb;27(2):273-8 PMID: 21592230
  35. The plasticity and stability of regulatory T cells.
    Nat Rev Immunol. 2013 Jun;13(6):461-7 PMID: 23681097
  36. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.
    J Immunol. 2011 Sep 1;187(5):2061-6 PMID: 21856944
  37. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.
    Blood. 2012 May 10;119(19):4430-40 PMID: 22438251
  38. Main features of human T helper 17 cells.
    Ann N Y Acad Sci. 2013 May;1284:66-70 PMID: 23651196
  39. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Hepatology. 2012 Oct;56(4):1342-51 PMID: 22505239
  40. TIM-3: a novel regulatory molecule of alloimmune activation.
    J Immunol. 2010 Nov 15;185(10):5806-19 PMID: 20956339
  41. Regulatory T cells: customizing for the clinic.
    Sci Transl Med. 2011 May 18;3(83):83ps19 PMID: 21593399
  42. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
    J Exp Med. 2008 Nov 24;205(12):2763-79 PMID: 19001139
Article Info
Journal
European journal of immunology
Abbr.
Eur J Immunol
ISSN
1521-4141
Published
2014-09-00
Epub
2014-00-16
Pages
2703-2711
Language
English
Region
Germany
NLM ID
1273201
PMCID
PMC4165702
Subset
IM
Grants
NIAID NIH HHS · U19 AI070352 · United States
NINDS NIH HHS · R37 NS024247 · United States
NCI NIH HHS · CA1061-A-18 · United States
NIAID NIH HHS · P01 AI039671 · United States
NINDS NIH HHS · NS2427 · United States
NIAID NIH HHS · U19 AI046130 · United States
NIAID NIH HHS · P01 AI073748 · United States
NIAID NIH HHS · P01 AI045757 · United States
NIAID NIH HHS · U01 AI102011 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com